Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Bone Disorders01:29

Bone Disorders

4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Bone Remodeling01:40

Bone Remodeling

38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.0K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.0K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

3.7K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.7K
What is the Skeletal System?01:02

What is the Skeletal System?

53.7K
Overview
53.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Machine learning derived abdominal aortic calcification is associated with physical frailty in community-dwelling adults: the UK Biobank Imaging Study.

GeroScience·2026
Same author

Associations between modifiable lifestyle risk factors and abdominal aortic calcification in the UK Biobank Imaging Study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

An explainable machine learning approach to predict fragility fractures and the identification of important features.

Scientific reports·2026
Same author

Validity of International Classification of Diseases (ICD)-9 and ICD-10 Codes for Medication-Related Osteonecrosis of the Jaw (MRONJ) Among Individuals Prescribed Antiresorptives for Fracture Prevention Across Two Cohorts.

Clinical epidemiology·2026
Same author

Automated abdominal aortic calcification, muscle health and incident falls: the UK Biobank Imaging Study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease and Kidney Transplant Outcomes.

Kidney international reports·2026

関連する実験動画

Updated: Sep 17, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.8K

オステオポロシス: 概要

Suzanne N Morin1, William D Leslie2, John T Schousboe3

  • 1Department of Medicine, McGill University, Montreal, Quebec, Canada.

JAMA
|June 30, 2025
PubMed
まとめ
この要約は機械生成です。

骨粗鬆症は数百万人に影響し 骨折のリスクが高まります 効果的な治療には 抗吸収薬や アナボリック薬 ライフスタイルの変化や 骨折を軽減し 治療結果を改善するための 骨折連絡サービスがあります

さらに関連する動画

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.3K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

659

関連する実験動画

Last Updated: Sep 17, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.8K
Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.3K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

659

科学分野:

  • ゲロントロジー
  • 整形外科
  • 薬理学について

背景:

  • 骨粗鬆症は,骨の質量と骨の脆弱性によって特徴づけられる一般的な疾患で,著しい罹病率,死亡率,経済的負担をもたらします.
  • 世界的に見ると 骨粗鬆症の骨折は 50歳以上の人口の大部分に影響し 3人に1人の女性と 5人に1人の男性に影響します

研究 の 目的:

  • 骨粗鬆症の現在の管理戦略を概説し,薬理学的介入とサポートケアに焦点を当てます.
  • 骨折の予防のためのリスク評価と個別化された治療アプローチの重要性を強調する.

主な方法:

  • 人口統計,病歴,骨のミネラル密度 (BMD) 測定を含む骨粗鬆症の危険因子のレビュー
  • 治療選択肢の評価:抗吸収剤 (ビスホスフォネート,デノスマブ) とアナボリック薬 (テリパラチド,アボロパラチド,ロモゾズマブ).
  • 骨折連絡サービスとライフスタイル変更 (カルシウム,ビタミンD,運動) が骨粗鬆症の管理における役割を評価する.

主要な成果:

  • 脊椎や股関節の骨折を減らすために,高リスクの患者に抗吸収薬が推奨されます.
  • アナボリック薬は,非常にリスクの高い個人に指示され,しばしば抗吸収療法が続きます.
  • 骨折関連サービスにより 薬の投与開始と投与の順守が改善され 後の骨折が減少します

結論:

  • 骨粗鬆症の治療には 薬剤療法,ライフスタイルの調整,そして協調したケアを組み合わせた 多面的なアプローチが必要です.
  • 早期に高リスクの患者を特定し,適切な治療法による早期の介入は,骨折のリスクを軽減し,患者のアウトカムを改善するために不可欠です.